Search

Peptide

Reference library

Educational peptide reference — research use only.

Research & educational use only

For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.

The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.

HCG

A glycoprotein hormone studied in fertility and endocrine research.

Half-life (approx.)
~24–36 h (approx., subQ)
Diluent
Bacteriostatic water (0.9% benzyl alcohol)
Common vials
5000, 10000 mg

Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.

Overview

HCG (human chorionic gonadotropin) is a glycoprotein hormone standardized in IU, studied for Leydig-cell stimulation and fertility-protocol research. Research materials are typically lyophilized with IU potency on the label — unit math differs from mg-based peptides. Glycoprotein hormone dosed in IU — distinct potency labeling from mg-based peptides.

Structure & identity

Glycoprotein hormone α/β subunits — 237 aa β chain

Sequence / structure
Glycoprotein hormone α/β subunits — 237 aa β chain

Status: FDA-approved for select indications; research use IU-based.

Mechanism

FDA-approved for select indications; research use IU-based.

Mimics LH action on Leydig cells, stimulating testosterone and progesterone synthesis. Leydig-cell testosterone synthesis via LH/CG receptor is the primary endocrine endpoint.

Studies & clinical programs

  • Hypogonadism research

    Published research models

    • Peer-reviewed literature documents endpoints under Hypogonadism research experimental designs.
  • Cryptorchidism models

    Published research models

    • Peer-reviewed literature documents endpoints under Cryptorchidism models experimental designs.
  • IVF trigger protocols

    Published research models

    • Peer-reviewed literature documents endpoints under IVF trigger protocols experimental designs.

Research models in literature

  • Hypogonadism research
  • Cryptorchidism models
  • IVF trigger protocols

Literature highlights

  • LH-receptor agonism on Leydig cells studied in hypogonadism and cryptorchidism research.
  • IVF trigger and luteal-support protocols use IU-based potency labeling.
  • Glycoprotein hormone with distinct storage and reconstitution requirements versus linear peptides.

Combination research notes

Fertility protocols may combine hCG with hMG or gonadorelin in controlled studies.

Key targets & pathways

LH/CG receptorLeydig cellsSteroidogenesis

Research areas

Leydig cell stimulationFertilityIU-based dosing

Routes in research literature

Subcutaneous

Also known as

Human Chorionic Gonadotropin

Handling cautions

  • Dose in IU, not mg — verify label conversion

Stability & storage phases

PhaseConditionGuidance
LyophilizedRefrigerated (2–8 °C); do not shake vialRecombinant proteins and glycoproteins require gentle handling; inspect cake integrity and store upright per IU potency literature.
ReconstitutedManufacturer diluent or bacteriostatic water, refrigeratedSwirl gently until dissolved — never shake vigorously; refrigerated stability is often shorter than small peptides (days to ~2 weeks).
Working aliquotsFrozen (−20 °C) in protein-grade tubesAliquot by IU or mg immediately after reconstitution; label concentration and avoid foam formation during draw.

Stability windows are formulation-dependent — verify published data and your lab SOP.

Reconstitution reference table

Vial (mg)Diluent (mL)mcg/mLUnits @ 100 mcgUnits @ 250 mcgUnits @ 500 mcg
500022500000.0000
1000025000000.0000

U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.

Reconstitution steps

  1. Allow vial to reach room temperature (15–30 min)
  2. Swab rubber stopper with alcohol prep pad
  3. Draw calculated bacteriostatic water into syringe
  4. Inject diluent slowly down vial wall — do not spray directly onto cake
  5. Gently swirl until fully dissolved — do not shake vigorously
  6. Label with date, concentration, and diluent volume
  7. Refrigerate and use within your lab stability window

IU-based dosing common; reconstitute per IU/mg label and protocol.

Laboratory record checklist

  • Potency stated in IU documented in lab records and analytical certificate when available
  • Lot and expiration recorded
  • Lyophilized cake intact
  • Reconstitution with supplied or BW per label
  • Refrigerate after mixing